Stage 1: normal level of consciousness, no focal neurological deficits
Stage 2: decreased level of counsciousness, significant focal neurological deficits
Stage 3: seizures, comatose
Epidemiology
About 1% of TB cases in Canada
Differential Diagnosis
Fungal meningitis
Sarcoidosis
Neoplasm
Risk Factors
Young
Female
Originally from endemic country
Previous TB
Presentation
History
Prodrome (1-3 weeks)
Personality changes
Low-grade fever
Malaise
Weight loss
Gradual onset of worsening headache
Headache
Fevers
Vomiting
Confusion
Personality changes
Photophobia (only 5-10%)
Seizures
Physical Exam
Meningeal symptoms
Fevers
Vomiting
Meningismus
Focal neurological deficits
Cranial nerve palsies in VI, III, and IV
Hemiplegia, paraplegia
Urinary retention
Confusion, coma
Investigations
Lumbar puncture
Increased lymphocytes, decreased glucose, and increased protein
Need 3-5mL of CSF for culture
May need serial LPs
CT head
Management
Rule out neoplasm and fungus, then start empiric treatment
HIV test (delay antiretrovirals by 8 weeks, though)
Standard HREZ x2mo then HR x7-10mo
Can replace ethambutol with a fluoroquinolone
Dexamethasone 3mg po qid x2wk then taper over 6-8wks
High risk of IRIS
Prognosis
Depends on stage at presentation
Mortality is high
Stage 1: 10-20%
Stage 2: 20-40%
Stage 3: 60%
Morbidity is high, with about 20% of patient being left with significant neurological sequelae
Mental retardation
Psychiatric disorders
Seizures
Blindness
Deafness
Ophthalmoplegia
Hemiparesis
References
^GE Thwaites, TTH Chau, K Stepniewska, NH Phu, LV Chuong, DX Sinh, NJ White, CM Parry, JJ Farrar. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. The Lancet. 2002;360(9342):1287-1292. doi:10.1016/s0140-6736(02)11318-3.